TetraLogic Pharmaceuticals Corporation
TLOG
$0.00
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -38.24% | -19.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -63.08% | -38.14% | |||
| Operating Income | 63.08% | 38.14% | |||
| Income Before Tax | -62.33% | 39.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -27.98% | 39.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.98% | 39.03% | |||
| EBIT | 63.08% | 38.14% | |||
| EBITDA | 63.11% | 37.76% | |||
| EPS Basic | -27.97% | 39.02% | |||
| Normalized Basic EPS | 43.71% | 28.45% | |||
| EPS Diluted | -28.49% | 39.47% | |||
| Normalized Diluted EPS | 43.71% | 28.45% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||